MASON STREET ADVISORS, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
MASON STREET ADVISORS, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$494,000
+19.9%
19,646
-0.6%
0.01%0.0%
Q3 2020$412,000
-12.0%
19,758
+0.2%
0.01%
-20.0%
Q2 2020$468,000
+42.2%
19,725
+7.9%
0.01%
+25.0%
Q1 2020$329,000
-24.0%
18,2730.0%0.01%0.0%
Q4 2019$433,000
-11.5%
18,273
+2.6%
0.01%
-20.0%
Q3 2019$489,000
-15.5%
17,809
+1.8%
0.01%
-16.7%
Q2 2019$579,000
-1.7%
17,486
+4.1%
0.01%0.0%
Q1 2019$589,000
+9.3%
16,803
+3.5%
0.01%
-7.7%
Q4 2018$539,000
-30.8%
16,228
+4.9%
0.01%
-18.8%
Q3 2018$779,000
-13.0%
15,471
+3.4%
0.02%
-20.0%
Q2 2018$895,000
+36.6%
14,957
+4.6%
0.02%
+33.3%
Q1 2018$655,000
+23.4%
14,297
+7.2%
0.02%
+25.0%
Q4 2017$531,000
+3.3%
13,333
+3.8%
0.01%
-7.7%
Q3 2017$514,000
-3.7%
12,840
+3.5%
0.01%0.0%
Q2 2017$534,000
+45.5%
12,400
+5.8%
0.01%
+44.4%
Q1 2017$367,000
+34.4%
11,720
+8.3%
0.01%
+28.6%
Q4 2016$273,000
+8.3%
10,818
+6.1%
0.01%0.0%
Q3 2016$252,000
+82.6%
10,192
+50.7%
0.01%
+75.0%
Q2 2016$138,000
+48.4%
6,763
+11.1%
0.00%
+33.3%
Q1 2016$93,000
+25.7%
6,088
+10.3%
0.00%
+50.0%
Q4 2015$74,000
+5.7%
5,520
+10.5%
0.00%0.0%
Q3 2015$70,000
+4.5%
4,996
+26.2%
0.00%0.0%
Q2 2015$67,0003,9590.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 42,189$1,220,9500.03%
MASSMUTUAL TRUST CO FSB/ADV 320$9,2610.00%
Versant Capital Management, Inc 16$4630.00%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders